ResMed Inc. Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss
ResMed Inc. (RSMDF) reported Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss of -$4.70 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-30.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2021-04-30
- ResMed Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2021-03-31 was -$4.70M.
- ResMed Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2020-12-31 was -$3.70M.
- ResMed Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2020-09-30 was $8.50M.
- ResMed Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2020-03-31 was -$9.10M.
| Period end | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month |
|---|---|---|---|
| 2021-03-31 | -$4.70M 10-Q · filed 2021-04-30 | -$8.40M derived: sum of 2 quarters · filed 2021-04-30 | $9.40M 10-Q · filed 2021-04-30 |
| 2020-12-31 | -$3.70M 10-Q · filed 2021-01-29 | $4.80M 10-Q · filed 2021-01-29 | |
| 2020-09-30 | $8.50M 10-Q · filed 2020-10-30 | ||
| 2020-03-31 | -$9.10M 10-Q · filed 2021-04-30 | -$11.90M derived: sum of 2 quarters · filed 2021-04-30 | -$14.50M 10-Q · filed 2021-04-30 |
| 2019-12-31 | -$2.80M 10-Q · filed 2021-01-29 | -$5.40M 10-Q · filed 2021-01-29 |